BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3881672)

  • 1. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.
    Arnaout MA; Hakim RM; Todd RF; Dana N; Colten HR
    N Engl J Med; 1985 Feb; 312(8):457-62. PubMed ID: 3881672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation and hypersensitivity reactions to dialysis membranes.
    Hakim RM; Breillatt J; Lazarus JM; Port FK
    N Engl J Med; 1984 Oct; 311(14):878-82. PubMed ID: 6332276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers.
    Hörl WH; Riegel W; Schollmeyer P; Rautenberg W; Neumann S
    Clin Nephrol; 1986 Jun; 25(6):304-7. PubMed ID: 3015463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of hemodialysis granulocytopenia and pulmonary leukostasis: A clinical manifestation of selective down-regulation of granulocyte responses to C5adesarg.
    Skubitz KM; Craddock PR
    J Clin Invest; 1981 May; 67(5):1383-91. PubMed ID: 7229031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis.
    Stroncek DF; Keshaviah P; Craddock PR; Hammerschmidt DE
    J Lab Clin Med; 1984 Sep; 104(3):304-11. PubMed ID: 6470561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The granulocytopenia of hemodialysis.
    N Engl J Med; 1985 Jun; 312(24):1578-9. PubMed ID: 3889642
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement as a mediator of granulocyte adherence and margination: studies based on the acute neutropenia of filtration leukapheresis.
    Fehr J
    Prog Clin Biol Res; 1977; 13():243-58. PubMed ID: 400757
    [No Abstract]   [Full Text] [Related]  

  • 8. Deficiency of two human leukocyte surface membrane glycoproteins (Mo1 and LFA-1).
    Arnaout MA; Dana N; Pitt J; Todd RF
    Fed Proc; 1985 Jul; 44(10):2664-70. PubMed ID: 3891419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
    Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
    N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis.
    Tielemans CL; Delville JP; Husson CP; Madhoun P; Lambrechts AM; Goldman M; Vanherweghem JL
    Clin Nephrol; 1993 Mar; 39(3):158-65. PubMed ID: 8096446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dysfunctional Mo1 glycoprotein is present on a subline of the KG1 acute myelogenous leukemia cell line.
    Dana N; Todd RF; Colten HR; Arnaout MA
    J Immunol; 1987 May; 138(10):3549-54. PubMed ID: 2437197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aprotinin on complement and granulocyte activation during ex vivo hemodialysis.
    Himmelfarb J; Holbrook D; McMonagle E
    Am J Kidney Dis; 1994 Dec; 24(6):901-6. PubMed ID: 7527183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo.
    DiScipio RG; Daffern PJ; Jagels MA; Broide DH; Sriramarao P
    J Immunol; 1999 Jan; 162(2):1127-36. PubMed ID: 9916743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane.
    Combe C; Pourtein M; de Précigout V; Baquey A; Morel D; Potaux L; Vincendeau P; Bézian JH; Aparicio M
    Am J Kidney Dis; 1994 Sep; 24(3):437-42. PubMed ID: 8079969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the dialysate fluid source of complement activating factors?
    Minetti L; Broggi ML; Civati G; Guastoni C; Teatini U
    Trans Am Soc Artif Intern Organs; 1985; 31():673-7. PubMed ID: 3879782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis.
    Himmelfarb J; McMonagle E; Holbrook D; Toth C
    J Lab Clin Med; 1995 Oct; 126(4):392-400. PubMed ID: 7561449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis granulocytopenia is preceded by an increased surface expression of the adhesion-promoting glucoprotein Mac-1.
    Lundahl J; Hed J; Jacobson SH
    Nephron; 1992; 61(2):163-9. PubMed ID: 1630540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation and neutropenia occurring during cardiopulmonary bypass.
    Hammerschmidt DE; Stroncek DF; Bowers TK; Lammi-Keefe CJ; Kurth DM; Ozalins A; Nicoloff DM; Lillehei RC; Craddock PR; Jacob HS
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):370-7. PubMed ID: 6970304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension.
    Slotman GJ; Burchard KW; Williams JJ; D'Arezzo A; Yellin SA
    Surgery; 1986 Jun; 99(6):744-51. PubMed ID: 3520916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.